Kuleana Technology
Private Company
Funding information not available
Overview
Kuleana Technology is a private, pre-revenue startup founded in 2020 to address the significant burdens of conventional in-center dialysis. The company is advancing a dual-technology platform: a portable, water-efficient dialysis machine developed at the University of Washington's Center for Dialysis Innovation (CDI), and a complementary needleless vascular access system. By untethering patients from clinic-based treatment and eliminating painful needle sticks, Kuleana aims to enable more frequent, convenient, and tolerable dialysis, potentially improving patient quality of life and clinical outcomes. The company maintains strong research partnerships with leading renal care institutions in the Pacific Northwest.
Technology Platform
Dual-platform comprising: 1) A portable, closed-loop dialysis system that regenerates dialysate, eliminating need for continuous water supply; and 2) A needleless vascular access technology for pain-free connection to the bloodstream.
Opportunities
Risk Factors
Competitive Landscape
Kuleana competes in the dialysis equipment and vascular access markets, dominated by large players like Fresenius and Baxter. Its direct competitors include other startups developing portable/wearable artificial kidneys (e.g., AWAK, NxStage prior to acquisition) and companies working on needleless access devices. Kuleana's differentiation is the potential combination of portability with pain-free access in an integrated system.